Reverie Labs

Reverie is attempting to disrupt, or rather supplement, the pharmaceuticals industry by using AI and Machine Learning, as well as a team of engineers and chemists, to develop new medicines.

• We put patients first – We aim to give hope to those who suffer from advanced cancer. From target selection to model creation, we ground our approach on what is most impactful for patients.
• We trust the data – Data is at the center of our decision-making process. We don’t believe in the guesswork of searching for molecules in the dark. Instead, we design methodical experiments to collect data and guide us forward.
• We value time – Time is our most finite resource and we value it accordingly. The more efficiently we move, the faster we can deliver a positive impact for patients. This urgency affects how we prioritize resources across our team, from optimizing model training to accelerating compound synthesis.
• We take ownership – Every member of our team has a responsibility for a component of our therapeutic goals. We empower our team members to take charge, make impactful decisions independently, and own the outcomes.
• We stay curious – Our communal curiosity facilitates a culture of openness and lifelong learning. At Reverie, we foster an environment of sharing experiences and expertise, as well as learning about others' in a no-ego environment. This curiosity cross-pollinates other departments, seeding ideas and inspiration into our everyday challenges.

Total funding: $25.2m